Neonatal Therapeutics: Considerations for Dosing

Abstract

Neonates are a uniquely vulnerable population, compromised by immature physiology and critical illness if born premature. Furthermore, neonates have frequent exposures to drugs that lack adequate data on safety, efficacy, and appropriate dosing in this population. Key physiologic differences between neonates and older children and adults affect drug absorption, distribution, metabolism, and elimination. Adequate understanding and consideration of these differences is essential to ensure optimal dosing of therapeutic agents in this vulnerable population. Moreover, direct study of neonates through appropriately designed pharmacokinetic and pharmacodynamic studies can ensure the development of safe and effective therapeutics in our youngest populations of patients.

Keywords

neonate - premature - pharmacokinetics - pharmacodynamic - drugs - absorption - distribution - metabolism - elimination - meropenem - acyclovir - physiology

• References

• 1 Costa HTML, Costa TX, Martins RR, Oliveira AG. Use of off-label and unlicensed medicines in neonatal intensive care. PLoS One 2018; 13 (09) e0204427
• 2 Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology--drug disposition, action, and therapy in infants and children. N Engl J Med 2003; 349 (12) 1157-1167
• 3 Huang NN, High RH. Comparison of serum levels following the administration of oral and parenteral preparations of penicillin to infants and children of various age groups. J Pediatr 1953; 42 (06) 657-658
• 4 Stamatas GN, Nikolovski J, Luedtke MA, Kollias N, Wiegand BC. Infant skin microstructure assessed in vivo differs from adult skin in organization and at the cellular level. Pediatr Dermatol 2010; 27 (02) 125-131
• 5 Evans NJ, Rutter N, Hadgraft J, Parr G. Percutaneous administration of theophylline in the preterm infant. J Pediatr 1985; 107 (02) 307-311
• 6 Kapitulnik J, Blondheim SH, Kaufmann NA. Sephadex absorption of bilirubin from neonatal and adult serum. Clin Chem 1972; 18 (01) 43-47
• 7 Caley DW, Maxwell DS. Development of the blood vessels and extracellular spaces during postnatal maturation of rat cerebral cortex. J Comp Neurol 1970; 138 (01) 31-47
• 8 Kimberlin DW, Lin CY, Jacobs RF. , et al; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001; 108 (02) 230-238
• 9 Cartlidge PH, Rutter N. Serum albumin concentrations and oedema in the newborn. Arch Dis Child 1986; 61 (07) 657-660
• 10 Rabalais GP, Nusinoff-Lehrman S, Arvin AM, Levin MJ. Antiviral susceptibilities of herpes simplex virus isolates from infants with recurrent mucocutaneous lesions after neonatal infection. Pediatr Infect Dis J 1989; 8 (04) 221-223
• 11 Haefeli WE, Schoenenberger RA, Weiss P, Ritz RF. Acyclovir-induced neurotoxicity: concentration-side effect relationship in acyclovir overdose. Am J Med 1993; 94 (02) 212-215
• 12 Sampson MR, Bloom BT, Lenfestey RW. , et al; Best Pharmaceuticals for Children Act–Pediatric Trials Network. Population pharmacokinetics of intravenous acyclovir in preterm and term infants. Pediatr Infect Dis J 2014; 33 (01) 42-49
• 13 Lacroix D, Sonnier M, Moncion A, Cheron G, Cresteil T. Expression of CYP3A in the human liver--evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur J Biochem 1997; 247 (02) 625-634
• 14 Miller RP, Roberts RJ, Fischer LJ. Acetaminophen elimination kinetics in neonates, children, and adults. Clin Pharmacol Ther 1976; 19 (03) 284-294
• 15 Mukherjee A, Dombi T, Wittke B, Lalonde R. Population pharmacokinetics of sildenafil in term neonates: evidence of rapid maturation of metabolic clearance in the early postnatal period. Clin Pharmacol Ther 2009; 85 (01) 56-63
• 16 Thakkar N, Gonzalez D, Cohen-Wolkowiez M. , et al. An opportunistic study evaluating pharmacokinetics of sildenafil for the treatment of pulmonary hypertension in infants. J Perinatol 2016; 36 (09) 744-747
• 17 Arant Jr BS. Developmental patterns of renal functional maturation compared in the human neonate. J Pediatr 1978; 92 (05) 705-712
• 18 United States National Library of Medicine. DailyMed. Available at: https://dailymed.nlm.nih.gov/ . Accessed February 15, 2019
• 19 Lutsar I, Chazallon C, Trafojer U. , et al. Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): a randomised controlled trial. bioRxiv 2018 . Doi: 10.1101/456871
• 20 Smith PB, Cohen-Wolkowiez M, Castro LM. , et al; Meropenem Study Team. Population pharmacokinetics of meropenem in plasma and cerebrospinal fluid of infants with suspected or complicated intra-abdominal infections. Pediatr Infect Dis J 2011; 30 (10) 844-849
• 21 van den Anker JN, Pokorna P, Kinzig-Schippers M. , et al. Meropenem pharmacokinetics in the newborn. Antimicrob Agents Chemother 2009; 53 (09) 3871-3879
• 22 Padari H, Metsvaht T, Kõrgvee LT. , et al. Short versus long infusion of meropenem in very-low-birth-weight neonates. Antimicrob Agents Chemother 2012; 56 (09) 4760-4764
• 23 Germovsek E, Lutsar I, Kipper K. , et al; NeoMero Consortium. Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: results from the NeoMero studies. J Antimicrob Chemother 2018; 73 (07) 1908-1916